, Regulation (EU) 2022/315

In forcesince 17 Dec 2021

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use [OJ L 311, 28.11.2001, p. 67.], and in particular Article 54a(2), point (d), thereof,

Whereas: